IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF
The invention describes an efficient platform for antibody manufacturing and formulation that provides i) cell culture process with improved feeding strategy resulting in high antibody titer between 2 gm/L to 5 gm/L; ii) improved purification process showing optimal percentage recovery, high purity...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | REDDY, Peddi Reddy Srinivas RAVINDRA, Yeolekar Leena CHAHAR, Singh Digamber SINGH, Chouhan Pankaj MHALASAKANT, Dhere Rajeev SHANKAR, Pisal Sambhaji DATTATRAY, Avalaskar Nikhil |
| description | The invention describes an efficient platform for antibody manufacturing and formulation that provides i) cell culture process with improved feeding strategy resulting in high antibody titer between 2 gm/L to 5 gm/L; ii) improved purification process showing optimal percentage recovery, high purity monomer content, minimum aggregation/particulate formation, minimum impurity levels; and iii) high concentration stable liquid formulation with optimal osmolality and low viscosity across different temperature excursions and devoid of aggregation. The preferred antibodies include IgG1 monoclonal antibody specific to the Dengue virus epitope in domain III of the E protein and IgG1 monoclonal antibody specific to the rabies virus surface G glycoprotein. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2020131251A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2020131251A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2020131251A13</originalsourceid><addsrcrecordid>eNqNjkFqAzEMRWeTRUl6B0G2KWQm9AAaWzMjsOViywnJJoTirkobSI_Yg9VJC-2yK4H09N-_az7ZP8WwJQuedAo2wRAikEwohmUEFOU-2D1UymajvGXdAwt49B4do4Ah58BkpzlS5WsSC3s-3N7HMdKIykHA5nhd2bCTpJHQr64un933uQoMpUTplpEUe0e_-j9kgtArstTOOlGkMCya2cvp9VLuf-a8WQ6kZnoo5_djuZxPz-WtfBxz6tbdut203WOL7eZ_1BexwlB5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF</title><source>esp@cenet</source><creator>REDDY, Peddi Reddy Srinivas ; RAVINDRA, Yeolekar Leena ; CHAHAR, Singh Digamber ; SINGH, Chouhan Pankaj ; MHALASAKANT, Dhere Rajeev ; SHANKAR, Pisal Sambhaji ; DATTATRAY, Avalaskar Nikhil</creator><creatorcontrib>REDDY, Peddi Reddy Srinivas ; RAVINDRA, Yeolekar Leena ; CHAHAR, Singh Digamber ; SINGH, Chouhan Pankaj ; MHALASAKANT, Dhere Rajeev ; SHANKAR, Pisal Sambhaji ; DATTATRAY, Avalaskar Nikhil</creatorcontrib><description>The invention describes an efficient platform for antibody manufacturing and formulation that provides i) cell culture process with improved feeding strategy resulting in high antibody titer between 2 gm/L to 5 gm/L; ii) improved purification process showing optimal percentage recovery, high purity monomer content, minimum aggregation/particulate formation, minimum impurity levels; and iii) high concentration stable liquid formulation with optimal osmolality and low viscosity across different temperature excursions and devoid of aggregation. The preferred antibodies include IgG1 monoclonal antibody specific to the Dengue virus epitope in domain III of the E protein and IgG1 monoclonal antibody specific to the rabies virus surface G glycoprotein.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200430&DB=EPODOC&CC=US&NR=2020131251A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200430&DB=EPODOC&CC=US&NR=2020131251A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>REDDY, Peddi Reddy Srinivas</creatorcontrib><creatorcontrib>RAVINDRA, Yeolekar Leena</creatorcontrib><creatorcontrib>CHAHAR, Singh Digamber</creatorcontrib><creatorcontrib>SINGH, Chouhan Pankaj</creatorcontrib><creatorcontrib>MHALASAKANT, Dhere Rajeev</creatorcontrib><creatorcontrib>SHANKAR, Pisal Sambhaji</creatorcontrib><creatorcontrib>DATTATRAY, Avalaskar Nikhil</creatorcontrib><title>IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF</title><description>The invention describes an efficient platform for antibody manufacturing and formulation that provides i) cell culture process with improved feeding strategy resulting in high antibody titer between 2 gm/L to 5 gm/L; ii) improved purification process showing optimal percentage recovery, high purity monomer content, minimum aggregation/particulate formation, minimum impurity levels; and iii) high concentration stable liquid formulation with optimal osmolality and low viscosity across different temperature excursions and devoid of aggregation. The preferred antibodies include IgG1 monoclonal antibody specific to the Dengue virus epitope in domain III of the E protein and IgG1 monoclonal antibody specific to the rabies virus surface G glycoprotein.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjkFqAzEMRWeTRUl6B0G2KWQm9AAaWzMjsOViywnJJoTirkobSI_Yg9VJC-2yK4H09N-_az7ZP8WwJQuedAo2wRAikEwohmUEFOU-2D1UymajvGXdAwt49B4do4Ah58BkpzlS5WsSC3s-3N7HMdKIykHA5nhd2bCTpJHQr64un933uQoMpUTplpEUe0e_-j9kgtArstTOOlGkMCya2cvp9VLuf-a8WQ6kZnoo5_djuZxPz-WtfBxz6tbdut203WOL7eZ_1BexwlB5</recordid><startdate>20200430</startdate><enddate>20200430</enddate><creator>REDDY, Peddi Reddy Srinivas</creator><creator>RAVINDRA, Yeolekar Leena</creator><creator>CHAHAR, Singh Digamber</creator><creator>SINGH, Chouhan Pankaj</creator><creator>MHALASAKANT, Dhere Rajeev</creator><creator>SHANKAR, Pisal Sambhaji</creator><creator>DATTATRAY, Avalaskar Nikhil</creator><scope>EVB</scope></search><sort><creationdate>20200430</creationdate><title>IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF</title><author>REDDY, Peddi Reddy Srinivas ; RAVINDRA, Yeolekar Leena ; CHAHAR, Singh Digamber ; SINGH, Chouhan Pankaj ; MHALASAKANT, Dhere Rajeev ; SHANKAR, Pisal Sambhaji ; DATTATRAY, Avalaskar Nikhil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2020131251A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>REDDY, Peddi Reddy Srinivas</creatorcontrib><creatorcontrib>RAVINDRA, Yeolekar Leena</creatorcontrib><creatorcontrib>CHAHAR, Singh Digamber</creatorcontrib><creatorcontrib>SINGH, Chouhan Pankaj</creatorcontrib><creatorcontrib>MHALASAKANT, Dhere Rajeev</creatorcontrib><creatorcontrib>SHANKAR, Pisal Sambhaji</creatorcontrib><creatorcontrib>DATTATRAY, Avalaskar Nikhil</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>REDDY, Peddi Reddy Srinivas</au><au>RAVINDRA, Yeolekar Leena</au><au>CHAHAR, Singh Digamber</au><au>SINGH, Chouhan Pankaj</au><au>MHALASAKANT, Dhere Rajeev</au><au>SHANKAR, Pisal Sambhaji</au><au>DATTATRAY, Avalaskar Nikhil</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF</title><date>2020-04-30</date><risdate>2020</risdate><abstract>The invention describes an efficient platform for antibody manufacturing and formulation that provides i) cell culture process with improved feeding strategy resulting in high antibody titer between 2 gm/L to 5 gm/L; ii) improved purification process showing optimal percentage recovery, high purity monomer content, minimum aggregation/particulate formation, minimum impurity levels; and iii) high concentration stable liquid formulation with optimal osmolality and low viscosity across different temperature excursions and devoid of aggregation. The preferred antibodies include IgG1 monoclonal antibody specific to the Dengue virus epitope in domain III of the E protein and IgG1 monoclonal antibody specific to the rabies virus surface G glycoprotein.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2020131251A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T10%3A55%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=REDDY,%20Peddi%20Reddy%20Srinivas&rft.date=2020-04-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2020131251A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |